DERM
Journey Medical Corp

3,065
Mkt Cap
$214.92M
Volume
90,496.00
52W High
$9.40
52W Low
$3.54
PE Ratio
-21.57
DERM Fundamentals
Price
$8.15
Prev Close
$7.92
Open
$8.02
50D MA
$7.89
Beta
0.63
Avg. Volume
225,257.42
EPS (Annual)
-$0.7181
P/B
8.07
Rev/Employee
$1.37M
Loading...
Loading...
News
all
press releases
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM
Sheets Smith Investment Management acquired a new position in shares of Journey Medical Corporation (NASDAQ:DERM - Free Report) during the 3rd quarter, according to the company in its most recent...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher - What's Next?
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher - Time to Buy...
MarketBeat·10h ago
News Placeholder
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts
Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are presently covering the firm, Marketbeat Ratings reports...
MarketBeat·21d ago
News Placeholder
FY2025 EPS Forecast for Journey Medical Decreased by Analyst
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Equities research analysts at HC Wainwright cut their FY2025 EPS estimates for shares of Journey Medical in a report released on Thursday...
MarketBeat·1mo ago
News Placeholder
B. Riley Increases Earnings Estimates for Journey Medical
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Analysts at B. Riley raised their FY2029 earnings per share (EPS) estimates for Journey Medical in a report issued on Thursday, November...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Forecasts Weaker Earnings for Journey Medical
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Research analysts at HC Wainwright cut their FY2026 earnings estimates for Journey Medical in a research report issued to clients and...
MarketBeat·1mo ago
News Placeholder
Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Journey Medical (NASDAQ:DERM - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.05) by...
MarketBeat·1mo ago
News Placeholder
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Journey Medical (DERM) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·1mo ago
News Placeholder
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -12.50% and -0.39%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Insights into Journey Medical's Upcoming Earnings
read more...
Benzinga·1mo ago
<
1
2
...
>

Latest DERM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.